Nebivolol recalls

Nebivolol products have been recalled 2 times, most recently on 17 Dec 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is nitrosamine impurity.

Total recalls2since 2024

Last 12 months1reported

Class I00% of total

Ongoing2latest 17 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 1 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 1 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why nebivolol is recalled

Nitrosamine Impurity150%
Other Reasons150%

Companies

Product types

Blood Pressure Medication2100%

By year

2025150%
2024150%

Ongoing nebivolol recalls

2 active

Reported	Class	Recall	Company	Reason	Where
17 Dec 2025Drug	CLASS III	Nebivolol Tablets, 20 mg recalled by Glenmark PharmaceuticalsNebivolol	Glenmark Pharmaceuticals Inc., USA	Other	Nationwide
25 Dec 2024Drug	CLASS II	Nebivolol Tablets recalled by Aurobindo Pharma USANebivolol	Aurobindo Pharma USA	Nitrosamine Impurity	Nationwide

All nebivolol recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
17 Dec 2025Drug	CLASS III	Nebivolol Tablets, 20 mg recalled by Glenmark PharmaceuticalsNebivolol	Glenmark Pharmaceuticals Inc., USA	Other	Nationwide
25 Dec 2024Drug	CLASS II	Nebivolol Tablets recalled by Aurobindo Pharma USANebivolol	Aurobindo Pharma USA	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.